 a
2.3% risk of stroke and death following CEA vs 3.6% for
CAS (P < .001). The difference in stroke was two-fold
higher for CAS in the general population as well as in
propensity-matched patient cohorts (HR, 2.23; 95% CI,
1.58-3.15; P < .001).

Transcarotid artery revascularization. Early data